MedTrace Logo

Telehealth Acceptance and Commitment Therapy for Older Veterans Experiencing Pandemic-Related Stress

NCT05433662 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2025-01-27

No results posted yet for this study

Summary

Older adults have been disproportionately impacted and distressed by the COVID-19 pandemic. Social distancing and stay-at-home orders have increased older adults' risk of social isolation and loneliness that will has led to a pandemic-induced fear of being in close proximity to other people. These fears and avoidant behaviors will have lasting effects if not treated with effective, safe, and convenient psychological interventions. This study will evaluate the acceptability and feasibility of delivering a small group intervention, called Acceptance and Commitment Therapy (ACT), through a telehealth modality to Veterans ages 65 and older who are experiencing pandemic-related emotional and physical distress. ACT helps decrease emotional suffering, improve well-being and promote positive behavior change by increasing one's psychological flexibility through the practice of mindfulness, acceptance, and values-based behaviors. The knowledge gained from this study will be used to better tailor the invention to meet the needs of older Veterans in an era of post-pandemic recovery.

Conditions

  • Psychological Stress

Interventions

BEHAVIORAL

Pandemic Acceptance and Commitment Therapy (Pan-ACT)

Pan-ACT is a 10-session, closed group, transdiagnostic intervention for older adults.

Sponsors & Collaborators

  • University of Alabama, Tuscaloosa

    collaborator OTHER

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Lori Lynne Davis, MD AB · Tuscaloosa VA Medical Center, Tuscaloosa, AL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-15
Primary Completion
2024-12-31
Completion
2025-01-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05433662 on ClinicalTrials.gov